ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Shukra Pharmaceuticals Limited has announced the direct listing of its equity shares on the NSE Main Board. Trading will commence under the symbol SHUKRAPHAR effective August 14, 2026.
The company filed its quarterly shareholding pattern under Regulation 31(1)(a). This report provides the current distribution of shares among promoter and public shareholders.
Shukra Pharmaceuticals Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026.
Shukra Pharmaceuticals Ltd filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed statutory compliance despite the company crossing specific regulatory thresholds.